Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Autism spectrum disorder (ASD) is very heterogeneous and multiple subtypes and etiologies likely exist. The maternal immune system has been implicated in the pathogenesis of some forms of ASD. Previous studies have identified the presence of specific maternal IgG autoantibodies with reactivity to fetal brain proteins at 37 and 73. kDa in up to 12% of mothers of children with ASD. The current study evaluates the presence of these autoantibodies in an independent cohort of mothers of 181 preschool-aged male children (131 ASD, 50 typically developing (TD) controls). We also investigated whether ASD children born to mothers with these autism-specific maternal IgG autoantibodies exhibit a distinct neural phenotype by evaluating total brain volume using structural magnetic resonance imaging (MRI). Of the 131 ASD children, 10 (7.6%) were born to mothers with the 37/73. kDa IgG autoantibodies (ASD-IgG). The mothers of the remaining ASD children and all TD controls were negative for these paired autoantibodies. While both ASD groups exhibited abnormal brain enlargement that is commonly observed in this age range, the ASD-IgG group exhibited a more extreme 12.1% abnormal brain enlargement relative to the TD controls. In contrast, the remaining ASD children exhibited a smaller 4.4% abnormal brain enlargement relative to TD controls. Lobar and tissue type analyses revealed that the frontal lobe is selectively enlarged in the ASD-IgG group and that both gray and white matter are similarly affected. These results suggest that maternal autoantibodies associated with autism spectrum disorder may impact brain development leading to abnormal enlargement.

Original languageEnglish (US)
Pages (from-to)61-65
Number of pages5
JournalBrain, Behavior, and Immunity
Volume30
DOIs
StatePublished - May 2013

Fingerprint

Autoantibodies
Mothers
Brain
Immunoglobulin G
Autism Spectrum Disorder
Fetal Proteins
Frontal Lobe
Autistic Disorder
Immune System
Magnetic Resonance Imaging
Phenotype

Keywords

  • Autism spectrum disorder
  • Autoantibody
  • Maternal antibody
  • MRI
  • Structural neuroimaging

ASJC Scopus subject areas

  • Immunology
  • Behavioral Neuroscience
  • Endocrine and Autonomic Systems

Cite this

@article{71a40496884748deab89e27c89f77ff6,
title = "Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder",
abstract = "Autism spectrum disorder (ASD) is very heterogeneous and multiple subtypes and etiologies likely exist. The maternal immune system has been implicated in the pathogenesis of some forms of ASD. Previous studies have identified the presence of specific maternal IgG autoantibodies with reactivity to fetal brain proteins at 37 and 73. kDa in up to 12{\%} of mothers of children with ASD. The current study evaluates the presence of these autoantibodies in an independent cohort of mothers of 181 preschool-aged male children (131 ASD, 50 typically developing (TD) controls). We also investigated whether ASD children born to mothers with these autism-specific maternal IgG autoantibodies exhibit a distinct neural phenotype by evaluating total brain volume using structural magnetic resonance imaging (MRI). Of the 131 ASD children, 10 (7.6{\%}) were born to mothers with the 37/73. kDa IgG autoantibodies (ASD-IgG). The mothers of the remaining ASD children and all TD controls were negative for these paired autoantibodies. While both ASD groups exhibited abnormal brain enlargement that is commonly observed in this age range, the ASD-IgG group exhibited a more extreme 12.1{\%} abnormal brain enlargement relative to the TD controls. In contrast, the remaining ASD children exhibited a smaller 4.4{\%} abnormal brain enlargement relative to TD controls. Lobar and tissue type analyses revealed that the frontal lobe is selectively enlarged in the ASD-IgG group and that both gray and white matter are similarly affected. These results suggest that maternal autoantibodies associated with autism spectrum disorder may impact brain development leading to abnormal enlargement.",
keywords = "Autism spectrum disorder, Autoantibody, Maternal antibody, MRI, Structural neuroimaging",
author = "Nordahl, {Christine W} and Daniel Braunschweig and Ana-Maria Iosif and Aaron Lee and Rogers, {Sally J} and Paul Ashwood and Amaral, {David G} and {Van de Water}, {Judith A}",
year = "2013",
month = "5",
doi = "10.1016/j.bbi.2013.01.084",
language = "English (US)",
volume = "30",
pages = "61--65",
journal = "Brain, Behavior, and Immunity",
issn = "0889-1591",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder

AU - Nordahl, Christine W

AU - Braunschweig, Daniel

AU - Iosif, Ana-Maria

AU - Lee, Aaron

AU - Rogers, Sally J

AU - Ashwood, Paul

AU - Amaral, David G

AU - Van de Water, Judith A

PY - 2013/5

Y1 - 2013/5

N2 - Autism spectrum disorder (ASD) is very heterogeneous and multiple subtypes and etiologies likely exist. The maternal immune system has been implicated in the pathogenesis of some forms of ASD. Previous studies have identified the presence of specific maternal IgG autoantibodies with reactivity to fetal brain proteins at 37 and 73. kDa in up to 12% of mothers of children with ASD. The current study evaluates the presence of these autoantibodies in an independent cohort of mothers of 181 preschool-aged male children (131 ASD, 50 typically developing (TD) controls). We also investigated whether ASD children born to mothers with these autism-specific maternal IgG autoantibodies exhibit a distinct neural phenotype by evaluating total brain volume using structural magnetic resonance imaging (MRI). Of the 131 ASD children, 10 (7.6%) were born to mothers with the 37/73. kDa IgG autoantibodies (ASD-IgG). The mothers of the remaining ASD children and all TD controls were negative for these paired autoantibodies. While both ASD groups exhibited abnormal brain enlargement that is commonly observed in this age range, the ASD-IgG group exhibited a more extreme 12.1% abnormal brain enlargement relative to the TD controls. In contrast, the remaining ASD children exhibited a smaller 4.4% abnormal brain enlargement relative to TD controls. Lobar and tissue type analyses revealed that the frontal lobe is selectively enlarged in the ASD-IgG group and that both gray and white matter are similarly affected. These results suggest that maternal autoantibodies associated with autism spectrum disorder may impact brain development leading to abnormal enlargement.

AB - Autism spectrum disorder (ASD) is very heterogeneous and multiple subtypes and etiologies likely exist. The maternal immune system has been implicated in the pathogenesis of some forms of ASD. Previous studies have identified the presence of specific maternal IgG autoantibodies with reactivity to fetal brain proteins at 37 and 73. kDa in up to 12% of mothers of children with ASD. The current study evaluates the presence of these autoantibodies in an independent cohort of mothers of 181 preschool-aged male children (131 ASD, 50 typically developing (TD) controls). We also investigated whether ASD children born to mothers with these autism-specific maternal IgG autoantibodies exhibit a distinct neural phenotype by evaluating total brain volume using structural magnetic resonance imaging (MRI). Of the 131 ASD children, 10 (7.6%) were born to mothers with the 37/73. kDa IgG autoantibodies (ASD-IgG). The mothers of the remaining ASD children and all TD controls were negative for these paired autoantibodies. While both ASD groups exhibited abnormal brain enlargement that is commonly observed in this age range, the ASD-IgG group exhibited a more extreme 12.1% abnormal brain enlargement relative to the TD controls. In contrast, the remaining ASD children exhibited a smaller 4.4% abnormal brain enlargement relative to TD controls. Lobar and tissue type analyses revealed that the frontal lobe is selectively enlarged in the ASD-IgG group and that both gray and white matter are similarly affected. These results suggest that maternal autoantibodies associated with autism spectrum disorder may impact brain development leading to abnormal enlargement.

KW - Autism spectrum disorder

KW - Autoantibody

KW - Maternal antibody

KW - MRI

KW - Structural neuroimaging

UR - http://www.scopus.com/inward/record.url?scp=84876829335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876829335&partnerID=8YFLogxK

U2 - 10.1016/j.bbi.2013.01.084

DO - 10.1016/j.bbi.2013.01.084

M3 - Article

C2 - 23395715

AN - SCOPUS:84876829335

VL - 30

SP - 61

EP - 65

JO - Brain, Behavior, and Immunity

JF - Brain, Behavior, and Immunity

SN - 0889-1591

ER -